http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-104688693-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-19 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P29-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-26 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-439 |
| filingDate | 2015-03-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2017-04-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2017-04-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-104688693-B |
| titleOfInvention | Hydrobromic acid lappaconitine powder-injection pharmaceutical composition for injection and preparation method |
| abstract | The invention discloses a hydrobromic acid lappaconitine powder-injection pharmaceutical composition for injection and a preparation method, and particularly discloses a hydrobromic acid lappaconitine powder-injection pharmaceutical composition for injection. The hydrobromic acid lappaconitine powder-injection pharmaceutical composition for injection comprises hydrobromic acid lappaconitine, mannitol and optional acid-base conditioning agents. Materials included in powder-injection comprise, by weight, four parts of the hydrobromic acid lappaconitine and five to 100 parts of the mannitol, and when the freeze-dried powder-injection is dissolved to solutions with the concentration of the hydrobromic acid lappaconitine of 4 mg/ml through water for injection, the pH value of the solutions ranges from 5.6 to 6.5. The hydrobromic acid lappaconitine powder-injection pharmaceutical composition for injection can be used as drugs for pain, especially the moderate pain and above, and has the good pharmaceutical property. |
| priorityDate | 2015-03-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 141.